Sunitinib Treatment for Patients with Advanced Clear-Cell Renal-Cell Carcinoma after Progression on Sorafenib

Publisher： Karger

E-ISSN： 1423-0232|76|5|350-354

ISSN： 0030-2414

Source： Oncology, Vol.76, Iss.5, 2009-03, pp. : 350-354

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sunitinib in Patients with Advanced Hepatocellular Carcinoma after Progression under Sorafenib Treatment

By  

Oncology, Vol. 79, Iss. 1-2, 2010-11 ,pp. : 85-92

Karger

Access to resources Recommend Favorite

Safety and efficacy of sunitinib for advanced non‐clear cell renal cell carcinoma

By  

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, Vol. 11, Iss. 4, 2015-12 ,pp. : 328-333

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy of Temsirolimus after Previous Treatment with Sunitinib, Sorafenib or Everolimus in Advanced Renal Cell Cancer

By  

Oncology, Vol. 80, Iss. 1-2, 2011-05 ,pp. : 34-41

Karger

Access to resources Recommend Favorite

Changes in Circulating Pro-Angiogenic Cytokines, other than VEGF, before Progression to Sunitinib Therapy in Advanced Renal Cell Carcinoma Patients

By  

Oncology, Vol. 84, Iss. 2, 2012-11 ,pp. : 115-122

Karger

Access to resources Recommend Favorite

Time to Recurrence after Nephrectomy as a Predictor of Cancer-Specific Survival in Localized Clear-Cell Renal Cell Carcinoma

By  

Urologia Internationalis, Vol. 86, Iss. 1, 2010-09 ,pp. : 47-52

Karger

Access to resources Recommend Favorite